Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Andrew Carr


Head of Department

  • Nuffield Professor of Orthopaedics
  • Director of the Musculoskeletal BRC Theme
  • Director of the Botnar Research Centre

Andrew Carr was born in Yorkshire and educated at Bradford Grammar School and Bristol University. He undertook postgraduate training and research in Bristol, Sheffield, Oxford and Melbourne. He led the specialist shoulder surgery service in Oxford and is a past President of the British Shoulder and Elbow Surgery Society. He has been Nuffield Professor of Orthopaedics, a fellow of Worcester College and Head of the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) at the University of Oxford since 2001. He has served on  University, Charity, Research Council and NHS trust boards and panels in the UK and worldwide.

His research has resulted in important contributions to improving the quality and outcome of surgery and the use of large scale multicentre surgical randomised controlled trials in orthopaedics. Carr is author or co-author of over 500 papers and review articles, including more than 20 in the Lancet and the BMJ, which have been cited over 29,000 times. As of 2019 Google Scholar h-index was 85.

He founded and directs the Botnar Research Centre, the Oxford University Institute of Musculoskeletal Sciences by securing a benefaction of over £20 million. The centre houses over 200 research staff and 75 post-graduate research students. He was Director of the NIHR Biomedical Research Unit in Oxford from 2008-2017 focussing on translational research. He was instrumental in the relocation of the Kennedy Institute for Rheumatology to Oxford and NDORMS in 2013 with an investment of over £60 million from the Kennedy Trust which accommodates over 200 research staff. He co-founded the Royal College of Surgeons of England Trial Unit in Oxford in 2012.

During his surgical training he worked with John Goodfellow in Oxford and defined the benefit to patients of partial knee replacement and the Oxford Knee has now been implanted in over 1.5 million patients worldwide. He has also pioneered the development of patient reported outcome scores for surgery which have been adopted by health providers and regulators worldwide, leading to policy changes and improved patient outcomes. The Oxford Scores and the Oxford Knee were both recognised for their impact in the Research Evaluation Framework (REF) 2014. His more recent work has included defining the use of placebo surgery controls in clinical trials. The CSAW placebo controlled trial of shoulder acromioplasty led to a rapid change of policy by NHS England and other health care providers worldwide and a significant reduction in the use of the operation with decrease in risk for patients and in healthcare costs. His laboratory currently investigates mechanisms of inflammation, repair and fibrosis in musculoskeletal disease. This work has led to the development of novel electrospun nanofibre surgical implants which are entering first in man clinical trials.

His awards include the Robert Jones Gold Medal of the British Orthopaedic Association, a Hunterian Professorship from the Royal College of Surgeons of England and the Steindler Award of the Orthopaedic Research Society in the USA. He is an NIHR senior investigator and was elected a fellow of the Academy of Medical Sciences in 2009. His research has featured on BBC Horizon, BBC News, CBS ‘the Doctors”, and in The Times, The Guardian, The Independent, The Daily Mail, The Daily Telegraph, The Observer, The New Statesman, The Economist, and as a cover story in Der Spiegel.